Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Cancer Registry Software Market

Cancer Registry Software Market Size

Report ID: GMI6266
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Cancer Registry Software Market Size

Cancer Registry Software Market size accounted for USD 71.4 million in 2022 and is estimated to grow at a CAGR of 10.5% to reach USD 193.4 million by 2032 attributed to the factors including rising cancer prevalence, increasing government initiatives for cancer treatment, growing adoption of EHR, and increasing emphasis on evidence-based medicine.

To get key market trends

Download Free Sample

The information gathered with the aid of cancer registry software aids in the development of therapeutics for the treatment of cancer by researchers and medical professionals and helps in preventing the global spread of diseases. The government can track the patients in a specific area and location with the aid of this software.

In August 2021, the researchers from the International Agency for Research on Cancer IARC, the Northern Ireland Cancer Registry, and the Union for International Cancer Control (UICC) launched new software to facilitate cancer staging. Additionally, in October 2020, MOVEMBER launched the largest network of prostate cancer patient registries in world. By leveraging the 'real world' experiences of more than 130,000 men, this network will have the power to revolutionise the treatment and care of the disease. This initiative provides a more efficient and affordable digital solution, which enhances the infrastructure and lowers costs

Cancer Registry Software Market Report Attributes
Report Attribute	Details
Base Year:	2022
Cancer Registry Software Market Size in 2022:	USD 71.4 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	10.5%
2032 Value Projection:	USD 193.4 Million
Historical Data for:	2018 to 2022
No. of Pages:	175
Tables, Charts & Figures:	306
Segments covered:	Product Type, Delivery Mode, Database, Functionality, End-User, and Region
Growth Drivers:	Increasing prevalence of cancer Increasing government initiatives for cancer treatment Growing adoption of EHR Increasing emphasis on evidence-based medicine Demand for data-driven cancer care
Pitfalls & Challenges:	Data privacy and security related concerns Limited awareness about cancer registry software in emerging markets Data interoperability and standardization challenges

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for cancer registry software was worth USD 71.4 million in 2022 and is poised to exhibit 10.5% CAGR to reach USD 193.4 million by 2032, driven by the rising prevalence of cancer.

The cancer registry software industry from the standalone software segment will expand at 10% CAGR to reach USD 143.7 million by 2032, attributed to the remarkable attributes of standalone software, including cost-effectiveness, flexibility, and ability to provide easy integration and data security.

Government organizations & third-party administration could witness 10% CAGR and dominate the end-use spectrum of the cancer registry software market due to increased investments and initiatives by these organizations in this space.

North America cancer registry software industry captured 51.6% market share in 2022, owing to the robust healthcare infrastructure and growing number of cancer cases in the region.